Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03214458 · ClinicalTrials.gov registry record · NA
Effects of Nasal High-flow Oxygen in Patients With an Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
A NA study, sponsored by Temple University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03214458 is a NA study that has completed, run by Temple University. The registered enrollment target is 10 participants.
The verdict
NCT03214458, a NA study, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The investigators are looking at the effect of humidified nasal high-flow with oxygen (HNHF-O2) on air exchange during exacerbations of COPD. HNHF-O2 therapy may have beneficial effects in patients with severe breathing impairment that results in low oxygen in the blood. Some studies show that patients with low blood oxygen levels who use HFNC oxygen have lower rates of needing mechanical ventilation.
Interventions
- DEVICE Nasal high flow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-07-20 |
| Est. Completion | 2018-04-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03214458
The ClinicalTrials.gov registry entry for NCT03214458 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nasal high flow is the first listed.
NCT03214458 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03214458 about?
NCT03214458 is a clinical study titled "Effects of Nasal High-flow Oxygen in Patients With an Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)". The investigators are looking at the effect of humidified nasal high-flow with oxygen (HNHF-O2) on air exchange during exacerbations of COPD. HNHF-O2 therapy may have beneficial effects in patients with severe breathing impairment that results in low oxygen in the blood. Some studies show that patie...
What is the current status of trial NCT03214458?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-07-20. Estimated completion is 2018-04-18.
What interventions are being tested in trial NCT03214458?
The interventions under investigation include: Nasal high flow (DEVICE).
Who is sponsoring clinical trial NCT03214458?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.